Parallel Advisors’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $482 | Buy |
+64
| New | +$482 | ﹤0.01% | 3285 |
|
|
2025
Q1 | – | Sell |
-1,317
| Closed | -$16K | – | 3519 |
|
|
2024
Q4 | $16K | Hold |
1,317
| – | – | ﹤0.01% | 2218 |
|
|
2024
Q3 | $22K | Hold |
1,317
| – | – | ﹤0.01% | 2031 |
|
|
2024
Q2 | $23K | Hold |
1,317
| – | – | ﹤0.01% | 1895 |
|
|
2024
Q1 | $22.4K | Hold |
1,317
| – | – | ﹤0.01% | 1916 |
|
|
2023
Q4 | $13.4K | Buy |
+1,317
| New | +$13.4K | ﹤0.01% | 2157 |
|
|
2023
Q2 | – | Sell |
-36
| Closed | -$368 | – | 3379 |
|
|
2023
Q1 | $368 | Buy |
+36
| New | +$368 | ﹤0.01% | 3196 |
|
|
2022
Q4 | – | Sell |
-10
| Closed | – | – | 3364 |
|
|
2022
Q3 | $0 | Sell |
10
-18
| -64% | – | ﹤0.01% | 3154 |
|
|
2022
Q2 | $0 | Buy |
28
+22
| +367% | – | ﹤0.01% | 3015 |
|
|
2022
Q1 | $0 | Buy |
+6
| New | – | ﹤0.01% | 2991 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3097 |
|